Abstract
- Background
An accumulating body of scientific evidence underscores the powerful therapeutic potential of a diet rich in fruits and vegetables in delaying, and frequently preventing, the onset of diverse chronic human pathologies, including cardiometabolic disorders, neurological conditions, musculoskeletal diseases, and specific malignancies. Among dietary constituents, glucosinolates—a unique class of sulfur- and nitrogen-containing phytochemicals found almost exclusively in cruciferous vegetables—have been identified through rigorous preclinical and clinical studies as major contributors to these health-promoting benefits. Current pharmacological and nutritional research indicates that glucosinolates and their downstream bioactive hydrolysis products (such as isothiocyanates) operate through multiple interconnected molecular mechanisms, ultimately exerting profound anti-inflammatory, antioxidant, and chemoprotective effects. This comprehensive review synthesizes contemporary knowledge regarding cruciferous vegetables and their characteristic glucosinolates in relation to the specified chronic health conditions.
- Methods
A systematic evaluation of the literature encompassing preclinical in vitro and in vivo studies alongside human clinical investigations was conducted. Data regarding dietary glucosinolate metabolism, tissue bioavailability, molecular mechanisms of action, and epidemiological or clinical disease-prevention outcomes were systematically compiled, critically appraised, and synthesized.
- Results
Synthesized findings indicate that while existing preclinical and observational evidence strongly links the regular consumption of high-glucosinolate diets with a reduced incidence and progression of chronic diseases, clinical translation remains nuanced. Specifically, while mechanistic and epidemiological data are highly promising, the current scientific literature underscores an explicit methodological need for future large-scale, placebo-controlled human clinical trials utilizing standardized glucosinolate supplements to definitively establish causal therapeutic efficacy and optimal dosing protocols.
- Conclusions
Glucosinolates from cruciferous vegetables hold substantial prophylactic and therapeutic promise against major chronic diseases. However, realizing their full clinical potential requires well-designed, large-scale human trials incorporating standardized interventions to overcome existing evidentiary gaps.
https://pmc.ncbi.nlm.nih.gov/articles/PMC8575925/